ULTY vs. FMED

Last updated Jun 16, 2026

ULTY (YieldMax Ultra Option Income Strategy ETF) and FMED (Fidelity Disruptive Medicine ETF) are both exchange-traded funds - ULTY is a Derivative Income fund actively managed by YieldMax, while FMED is a Health & Biotech Equities fund actively managed by Fidelity. Both are actively managed. Over the past year, ULTY returned 7.83% vs 8.53% for FMED. A 0.52 correlation means they provide meaningful diversification when combined. ULTY charges 1.14%/yr vs 0.50%/yr for FMED.

Performance

ULTY vs. FMED - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in YieldMax Ultra Option Income Strategy ETF (ULTY) and Fidelity Disruptive Medicine ETF (FMED). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ULTY achieves a 11.58% return, which is significantly higher than FMED's -4.75% return.

ULTY

• 1D: 2.56%
• 1M: 3.18%
• YTD: 11.58%
• 6M: 13.08%
• 1Y: 7.83%
• 3Y*: —
• 5Y*: —
• 10Y*: —

FMED

• 1D: 0.90%
• 1M: 7.10%
• YTD: -4.75%
• 6M: -6.17%
• 1Y: 8.53%
• 3Y*: 0.73%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

ULTY vs. FMED - Yearly Performance Comparison

	2026 (YTD)	2025	2024
ULTY YieldMax Ultra Option Income Strategy ETF	11.58%	-0.84%	-4.73%
FMED Fidelity Disruptive Medicine ETF	-4.75%	9.69%	-2.66%

Correlation

The correlation between ULTY and FMED is 0.45, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.45
Correlation (All Time) Calculated using the full available price history since Feb 29, 2024	0.52

The correlation between ULTY and FMED has been stable across timeframes, ranging from 0.45 to 0.52 - a consistent structural relationship.

ULTY vs. FMED - Sectors Allocation Comparison

Sectors	ULTY	FMED
Technology	52.3%	0.9%
Basic Materials	12.0%	-
Industrials	10.6%	-
Financial Services	9.8%	-
Communication Services	7.6%	-
Consumer Cyclical	6.6%	-
Healthcare	1.1%	97.1%
Consumer Defensive	0.0%	-
Energy	-	-
Real Estate	-	-
Utilities	-	-

Return for Risk

ULTY vs. FMED — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ULTY

ULTY Risk / Return Rank: 14
ULTY Sharpe Ratio Rank: 15
ULTY Sortino Ratio Rank: 14
ULTY Omega Ratio Rank: 14
ULTY Calmar Ratio Rank: 13
ULTY Martin Ratio Rank: 12

FMED

FMED Risk / Return Rank: 15
FMED Sharpe Ratio Rank: 16
FMED Sortino Ratio Rank: 16
FMED Omega Ratio Rank: 15
FMED Calmar Ratio Rank: 14
FMED Martin Ratio Rank: 14

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ULTY vs. FMED - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for YieldMax Ultra Option Income Strategy ETF (ULTY) and Fidelity Disruptive Medicine ETF (FMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ULTY	FMED	Difference
Sharpe ratio: Return per unit of total volatility	0.36	0.44	-0.08
Sortino ratio: Return per unit of downside risk	0.62	0.79	-0.18
Omega ratio: Gain probability vs. loss probability	1.08	1.09	-0.01
Calmar ratio: Return relative to maximum drawdown	0.33	0.47	-0.14
Martin ratio: Return relative to average drawdown	0.63	1.03	-0.41

ULTY vs. FMED - Sharpe Ratio Comparison

The current ULTY Sharpe Ratio is 0.36, which is comparable to the FMED Sharpe Ratio of 0.44. The chart below compares the historical Sharpe Ratios of ULTY and FMED, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

ULTY vs. FMED - Drawdown Comparison

The maximum ULTY drawdown since its inception was -26.85%, which is greater than FMED's maximum drawdown of -21.84%. Use the drawdown chart below to compare losses from any high point for ULTY and FMED.

Drawdown Indicators

	ULTY	FMED	Difference
Max Drawdown Largest peak-to-trough decline	-26.85%	-21.84%	-5.01%
Max Drawdown (1Y) Largest decline over 1 year	-24.16%	-18.33%	-5.83%
Max Drawdown (3Y) Largest decline over 3 years	—	-21.84%	—
Current Drawdown Current decline from peak	-8.51%	-10.64%	+2.13%
Average Drawdown Average peak-to-trough decline	-9.89%	-7.09%	-2.80%
Ulcer Index Depth and duration of drawdowns from previous peaks	12.48%	8.27%	+4.21%

Volatility

ULTY vs. FMED - Volatility Comparison

YieldMax Ultra Option Income Strategy ETF (ULTY) has a higher volatility of 8.42% compared to Fidelity Disruptive Medicine ETF (FMED) at 7.50%. This indicates that ULTY's price experiences larger fluctuations and is considered to be riskier than FMED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ULTY	FMED	Difference
Volatility (1M) Calculated over the trailing 1-month period	8.42%	7.50%	+0.92%
Volatility (6M) Calculated over the trailing 6-month period	16.58%	15.01%	+1.57%
Volatility (1Y) Calculated over the trailing 1-year period	21.69%	19.37%	+2.32%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	27.35%	18.57%	+8.78%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	27.35%	18.57%	+8.78%

ULTY vs. FMED - Expense Ratio Comparison

ULTY has a 1.14% expense ratio, which is higher than FMED's 0.50% expense ratio.

Dividends

ULTY vs. FMED - Dividend Comparison

ULTY's dividend yield for the trailing twelve months is around 110.56%, while FMED has not paid dividends to shareholders.

Position	TTM	2025	2024
FMED Fidelity Disruptive Medicine ETF	0.00%	0.00%	0.46%
ULTY YieldMax Ultra Option Income Strategy ETF	110.56%	142.99%	111.70%

Frequently Asked Questions

Can I hold both ULTY and FMED in my portfolio?

ULTY and FMED have a correlation of 0.45, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ULTY or FMED?

ULTY has higher volatility (8.42%) compared to FMED (7.50%). In terms of maximum drawdown, ULTY dropped -26.85% vs FMED's -21.84%.

Which ETF is better, ULTY or FMED?

On 1-year performance, FMED leads with 8.53% vs 7.83% for ULTY. On fees, FMED is cheaper at 0.50% per year. On volatility, FMED has been the lower-risk option at 7.50%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, ULTY or FMED?

Over the 1-year period, FMED has performed better with a 8.53% return vs 7.83%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, ULTY or FMED?

FMED is cheaper with a 0.50% expense ratio, compared with 1.14% for ULTY.

Which ETF pays a higher dividend yield, ULTY or FMED?

ULTY has the higher dividend yield at 110.56%, compared with 0.00% for FMED.

What is the main difference between ULTY and FMED?

ULTY is categorized as Derivative Income, while FMED is Health & Biotech Equities. They also come from different issuers: YieldMax and Fidelity. Their fees differ too: 1.14% for ULTY and 0.50% for FMED.

Which has better risk-adjusted returns?

FMED currently has the higher Sharpe Ratio (0.44 vs 0.36), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.